School of Medicine

Beginning Wednesday, Aug. 2, applications will be open for the School of Medicine’s Executive Management Fellowship, a two-year program designed to provide participants with exposure to the operation and governance of a nationally ranked, research-based medical school and academic medical center.

Derek E. Byers, MD, PhD, has been named executive chair of the university’s Institutional Review Board, which reviews and approves protocols for research studies that involve human subjects. He begins the new role Tuesday, Aug. 1.

With support from a $3 million grant from the National Institutes of Health (NIH), a multidisciplinary team led by Hong Chen at the McKelvey School of Engineering seeks to integrate ultrasound with genetics to precisely modify neurons in the brain.

The Division of Physician-Scientists at the School of Medicine has named its 2023 Dean’s Scholars. The awardees will receive up to two years of financial support and mentorship, as well as dedicated lab time to conduct scientific research.

David T. Curiel, MD, PhD, and Michael S. Diamond, MD, PhD, both of the School of Medicine, have received the Chancellor’s Award for Innovation and Entrepreneurship for their development of a nasal vaccine against the virus that causes COVID-19.

Researchers at the School of Medicine helped lead a major study, funded by the National Institutes of Health (NIH), that uncovered rich cellular and molecular diversity in healthy and diseased kidneys, creating a kidney tissue atlas that will help further understanding of kidney injury and disease.

Neuroscience researchers Tom Franken, MD, PhD, and Alessandro Livi, PhD, at the School of Medicine, are among the recipients of this year’s McDonnell Center for Systems Neuroscience Small Grants.

Philip R.O. Payne has been named an inaugural Janet and Bernard Becker Professor at the School of Medicine. He was installed by Chancellor Andrew D. Martin and David Perlmutter, MD, executive vice chancellor for medical affairs.

Researchers at the School of Medicine and Lund University in Sweden have identified a form of tau that could serve as a marker to track Alzheimer’s progression. The marker also could speed drug development.

A surgical team from the School of Medicine recently performed the first robotic liver transplant in the U.S. in May at Barnes-Jewish Hospital.